Epidemiology of Hepatitis B and Associated Liver Diseases in China

Yao Zhang; Hua Zhang; Au Elizabeth; Xiao-qing Liu

Your Location：

Home >

Browse articles >

Epidemiology of Hepatitis B and Associated Liver Diseases in China

null Issue 4, Pages: 243-248(2012)

Updated：2024-04-10

- Epidemiology of Hepatitis B and Associated Liver Diseases in China
- Affiliations：
  
  1. Department of Infectious Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College,Beijing,China,100730
  2. Office of Research Adminstration, Chinese Academy of Medical Sciences & Peking Union Medical College,Beijing,China,100730
  3. ,China
  4. Department of Medicine, Tufts University School of Medicine,Boston,USA,02111
- Author bio：
- Funds：
- DOI：
  CLC：
- Published Online：07 January 2013，
  
  Published：2012
- Accepted：
Scan QR Code
Yao Zhang, Hua Zhang, Au Elizabeth, et al. Epidemiology of Hepatitis B and Associated Liver Diseases in China[J]. Null, 2012, (4): 243-248.
DOI：

Yao Zhang, Hua Zhang, Au Elizabeth, et al. Epidemiology of Hepatitis B and Associated Liver Diseases in China[J]. Null, 2012, (4): 243-248. DOI：

摘要

Hepatitis B virus (HBV) infection has long been a critical public health challenge in China. National surveys revealed a prevalence of approximate 10% for chronic HBV infection in general population. HBV has been the leading cause of chronic hepatitis

cirrhosis

and liver cancers in Chinese population and a common pathogen of acute viral hepatitis. Meanwhile

the epidemic provided important opportunities to research the natural history

public health impact

and therapeutic and preventive interventions for HBV in China. In this review

we summarized the selected key epidemiological studies since 1970s regarding HBV infection and its associated liver diseases in China

and provided considerations for future research

prevention and treatment of HBV.

Abstract

Abstract Hepatitis B virus (HBV) infection has long been a critical public health challenge in China. National surveys revealed a prevalence of approximate 10% for chronic HBV infection in general population. HBV has been the leading cause of chronic hepatitis

cirrhosis

and liver cancers in Chinese population and a common pathogen of acute viral hepatitis. Meanwhile

the epidemic provided important opportunities to research the natural history

public health impact

and therapeutic and preventive interventions for HBV in China. In this review

we summarized the selected key epidemiological studies since 1970s regarding HBV infection and its associated liver diseases in China

and provided considerations for future research

prevention and treatment of HBV.

关键词

Keywords

references

Views

3194

Downloads

CSCD

Alert me when the article has been cited

Submit

Publicity Resources

STUDY ON SMALL HEPATOCELLULAR CARCINOMA AND ITS EXTENSION

NATIONAL SURVEY ON PREVALENCE OF CANCER PAIN

TRENDS OF CASE DETECTION AND OTHER INDICATORS OF LEPROSY IN CHINA DURING 1985-2002

IN VIVO ¹ H MAGNETIC RESONANCE SPECTROSCOPY IN EVALUATION OF HEPATOCELLULAR CARCINOMA AND ITS EARLY RESPONSE TO TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION

Application of Positron Emission Tomography Molecular Probes in Hepatocellular Carcinoma Biological Imaging

Related Author

and Jia-he Tian

Ting-ting He

and Bao-cai Xing

Ke-min Jin

Li Zhou

Ye Jin

Jing-hua Zhang

Gang Xu

Related Institution

Chetpet

India Council of Medical Research

Jian-ping Shen1*, M.D. Gupte2, Cheng Jiang1, P. Manickam2, Mei-wen Yu1, and Wen-zhong Li1 1Institute of Dermatology, Chinese Academy of Medical Sciences & Peking Union Medical College, National Center for STD and Leprosy Control, Nanjing 210042 2National Institute of Epidemiology, India Council of Medical Research, Chetpet

Department of Nuclear Medicine, General Hospital of the Chinese People’s Liberation Army

Department of General Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College

⁰